Trump Initiates "Agreement Surge," Multiple Nations Respond
On July 22, U.S. President Trump announced three trade agreements with Japan, the Philippines, and Indonesia, covering tariff arrangements, market opening, and massive investment plans. This "triple agreement" move is widely interpreted as a strategic pressure tactic before the August 1 tariff deadline, aiming to force the EU into making greater concessions in the upcoming negotiations.
Details of the agreements reveal that the U.S. will impose a 15% tariff on Japanese goods, while goods from the Philippines and Indonesia will face a 19% tariff. Meanwhile, all three countries have committed to opening their markets, with Japan pledging to invest $550 billion in the U.S. and easing market access for automobiles and agriculture. Indonesia, in its joint statement, announced a 99% tariff exemption on U.S. products.
EU Pushed to Negotiation Edge, Countermeasures Ready
Facing the U.S. tariff "countdown," EU negotiators are set to visit Washington on July 23 for final talks. Trump has warned that without an agreement, a 30% tariff on goods from all EU member states will begin on August 1. U.S. Commerce Secretary Luttig has made it clear that the deadline "will not be extended."
Although Luttig left room for further talks by saying negotiations could continue after tariffs are imposed, the EU does not intend to sit back. Brussels has prepared three rounds of retaliation plans, with the first wave of counter-tariffs possibly starting as early as August 6, covering EUR 21 billion worth of U.S. products. If talks fail, retaliation could extend further into services and digital sectors.
Pharmaceutical Pricing Sparks New Conflict Focus
Apart from tariff disputes, Trump is also pressuring the EU to raise prescription drug prices to reduce the cost for American consumers. He threatened to ban European car brands like Mercedes, BMW, and Volkswagen from the U.S. market if Europe does not increase drug prices.
Trump cited the "price gap" of the weight-loss drug Ozempic as an example, criticizing Europe's "subsidy structure" that affects U.S. drug prices and emphasized that his "most-favored-nation pricing" policy requires international cooperation. If the EU does not comply, the U.S. might target core European export sectors as a response.
EU Adopts a Tougher Stance, Trade Tool Ready for Use
Tensions are rising, and there is increasing support within the EU to activate the "anti-coercion instrument." This mechanism will authorize the European Commission to swiftly respond to unfair trade practices with targeted sanctions, digital service taxes, and other measures. Foreign media speculate that if the U.S. imposes broad tariffs, the EU may fully retaliate by September.
The European Commission has assessed that current U.S. tariff policies affect 70% of EU exports to the U.S., involving up to EUR 380 billion annually. Data shows the U.S.-EU trade deficit is expected to reach $235.6 billion in 2024, a historical high, further exacerbating tensions.
Multilateral Trade Structure Faces Reshaping
The Trump administration’s tariff restructuring is seen as an attempt to "use tariffs as agreements," aiming to restore U.S. dominance in the global trade system. However, experts warn that such "unilateral ultimatum-style" actions might weaken the basis for multilateral negotiations and exacerbate global economic fragmentation.
With August 1 approaching, the market is closely watching whether U.S.-EU talks can prevent a full-scale conflict. If both sides reach a compromise, global markets will have a brief respite; otherwise, a new round of trade tensions may arise in the coming months. For global investors, these trade developments are now a crucial variable in assessing policy risk and asset allocation.
